Role of Prophylactic Transamine in Reducing Blood Loss during Elective Cesarean Delivery
DOI:
https://doi.org/10.51253/pafmj.v74iSUPPL-2.7845Keywords:
Blood Loss, Hemoglobin, TransamineAbstract
Objective: The purpose of the current research was to see how effective Tranexamic Acid is for minimizing loss of blood after
elective cesarean section.
Study Design: Interventional, randomized, parallel-group study.
Place and Duration of Study: Department of Obstetrics and Gynecology, Pak Emirates Military Hospital, Rawalpindi Pakistan,
from August 2020 to August 2021.
Methodology: Computer-generated random number tables were used to assign 130 females wo were scheduled for cesarean
surgery to the Study or Control groups. The research group received TXA and regular treatment, while control group received
just routine care. The gravimetric technique was used to determine blood loss in both groups. The percentage difference
between hemoglobin levels before and after the operation was determined, the blood loss and percentage drop in hemoglobin
were the primary outcome variables. The secondary outcomes of the study include the duration of operation, adverse effects,
percentage of patients who lost more than 500ml blood and require for additional uterotonics. The outcome variables were
compared using the unpaired t-test and the Chi-square test.
Results: Blood loss was significantly lower in the study group from placental delivery until the end of the operation. In the
study group, 5(9.3%) of patients had a drop in hemoglobin of more than 10%, whereas 25(39%) of subjects had a drop of more
than 10% loss of blood in the process of Lower Segment Caesarean Section.
Conclusion: TXA may be administered safely and successfully in Lower Segment Caesarean Section as its use was not linked to
any adverse effects.
Downloads
References
Kamilya G, Seal SL, Mukherji J, Bhattacharyya SK, Hazra A.
Maternal mortality and cesarean delivery: an analytical
observational study. Journal of Obstetrics and Gynaecology
Research. 2018; 36(2): 248–253.
Ronsmans C, Graham WJ, group LMSS steering. Maternal
mortality: who, when, where, and why. The lancet 2016; 368(9542):
–1200.
Mohamed El-Seadawy Ghanem A, Fawzy Mohamed M, Khamis
Galal S. ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN
REDUCING BLOOD LOSS DURING ELECTIVE CESAREAN
SECTION. Al-Azhar Medical Journal 2021; 50(3): 1871–1880.
Geller SE, Goudar SS, Adams MG, Naik VA, Patel A, Bellad MB, et
al. Factors associated with acute postpartum hemorrhage in lowrisk women delivering in rural India. International Journal of
Gynecology & Obstetrics 2018; 101(1): 94–99.
Dyer RA, Butwick AJ, Carvalho B. Oxytocin for labor and
caesarean delivery: implications for the anaesthesiologist. Current
Opinion in Anesthesiology 2017; 24(3): 255–261.
Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Antifibrinolytic agents in post partum haemorrhage: a systematic
review. BMC pregnancy and childbirth 2019; 9(1): 1–6.
Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ,
Fergusson DA, et al. Antifibrinolytic use for minimizing
perioperative allogeneic blood transfusion. Cochrane database of
systematic reviews 2018; (1).
Matteson KA, Rahn DD, Wheeler TL. Non-surgical management
of heavy menstrual bleeding: A systematic review and practice
guidelines. Obstetrics and gynecology 2019; 121(3): 632.
Sentilhes L, Winer N, Azria E, Sénat M-V, Le Ray C, Vardon D, et
al. Tranexamic acid for the prevention of blood loss after vaginal
delivery. New England Journal of Medicine 2018; 379(8): 731–742.
Ducloy-Bouthors A-S, Jude B, Duhamel A, Broisin F, Huissoud C,
Keita-Meyer H, et al. High-dose tranexamic acid reduces blood
loss in postpartum haemorrhage. Critical care 2017; 15(2): 1–10.
Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous
tranexamic acid administration on blood loss during and after
cesarean delivery. Int J Gynecol Obstet 2018; 115(3): 224–226.
Geller SE, Goudar SS, Adams MG, Naik VA, Patel A, Bellad MB, et
al. Factors associated with acute postpartum hemorrhage in lowrisk women delivering in rural India. Int J Gynaecol Obstet 2008;
(1): 94-99.
https://doi.org/10.1016/j.ijgo.2007.08.025
Shahid A, Khan A. Tranexamic acid in decreasing blood loss
during and after caesrean section. J Coll Physcian Surg Pak 2013;
(7): 459-462.
Dunn CJ, Goa KL. Tranexamic acid. Drugs 2018; 57(6): 1005–1032.
Walzman M, Bonnar J. Effects of tranexamic acid on the
coagulation and fibrinolytic systems in pregnancy complicated by
placental bleeding. In: New Toxicology for Old Springer; 2017:
–220.
Picetti R, Shakur-Still H, Medcalf RL, Standing JF, Roberts I. What
concentration of tranexamic acid is needed to inhibit fibrinolysis?
A systematic review of pharmacodynamics studies. Blood
Coagulation & Fibrinolysis 2019; 30(1): 1.
Pabinger I, Fries D, Schöchl H, Streif W, Toller W. Tranexamic acid
for treatment and prophylaxis of bleeding and hyperfibrinolysis.
Wiener klinische Wochenschrift. 2017; 129(9): 303–316.
Gai M, Wu L, Su Q, Tatsumoto K. Clinical observation of blood
loss reduced by tranexamic acid during and after caesarian
section: a multi-center, randomized trial. European Journal of
Obstetrics & Gynecology and Reproductive Biology 2019; 112(2):
–157.
Falana O, Patel G. Efficacy and safety of tranexamic acid versus ϵaminocaproic acid in cardiovascular surgery. Annals of
Pharmacotherapy 2017; 48(12): 1563–1569.
Takagi H, Ando T, Umemoto T. Seizures associated with
tranexamic acid for cardiac surgery: A meta-analysis of
randomized and non-randomized studies. The Journal of
cardiovascular surgery 2017; 58(4): 633–641.
Yehia AH, Koleib MH, Abdelazim IA, Atik A. Tranexamic acid
reduces blood loss during and after cesarean section: a double
blinded, randomized, controlled trial. Asian Pacific Journal of
Reproduction 2019; 3(1): 53–56.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Saima Irfan, Tehreem Yazdani, Salma Nisar, Maliha Khawar, Hira Shafqat
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.